Markets, led by financial stocks, start to recover from Monday's dip >>> READ MORE

NVS

Avoid These 7 Big-Name Biotechs and Pharmaceuticals

Biotech and pharmaceutical companies headed lower and not because of the election. Here's why you should sell these stocks More 

PFE Stock: Ignore Pfizer Inc.’s Earnings Miss at Your Own Peril

Pfizer missed on earnings, and PFE stock slipped as a result. But even if you don't own Pfizer, you don't want to ignore what's happening there. More 

11 Pharmaceuticals Stocks to Sell Now

The ratings of 11 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

7 Healthcare Stocks That Are Investor Poison

You can't blindly buy stocks in healthcare because there are some that have some serious problems. More 

11 Pharmaceuticals Stocks to Sell Now

This week, the overall grades of 11 Pharmaceuticals stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

6 More Pharma Companies Selling Overpriced Drugs

Overpriced drugs are more common with the pharma industry than most realize, and these names are the worst offenders. More 

Merck & Co., Inc. Features Slow and Steady Dividend Growth (MRK)

Merck is a blue-chip dividend stock that may be a solid investment, however MRK's dividend growth lags other competitors More